Loading...
Loading...
TARO| Name | Value |
|---|---|
| Revenues | 148.2M |
| Cost of Revenue | 74.6M |
| Gross Profit | 73.6M |
| Operating Expense | 68.9M |
| Operating I/L | 4.7M |
| Other Income/Expense | 12.9M |
| Interest Income | 14.0M |
| Pretax | 17.7M |
| Income Tax Expense | 9.1M |
| Net Income/Loss | 8.5M |
Taro Pharmaceutical Industries Ltd. is a science-based pharmaceutical company that develops, manufactures, and markets prescription and over-the-counter pharmaceutical products globally. The company also produces active pharmaceutical ingredients for use in its finished dosage form products. Its product portfolio covers a wide range of therapeutic categories, including allergy, analgesic, antibacterial, cardiovascular, dermatology, and gastrointestinal medications. Taro distributes its products directly to wholesalers, retail drug store chains, hospitals, and other direct purchasers. The company generates revenue through the sale of its pharmaceutical products in various forms such as tablets, creams, injectables, and suspensions.
